Stenocare A/S (FRA:S7C)

Market Cap	5.78M +145.9%
Revenue (ttm)	1.24M +397.1%
Net Income	-114.43K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1315
Previous Close	0.1330
Day's Range	0.1295 - 0.1315
52-Week Range	0.0598 - 0.3460
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Stenocare

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 4
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S7C

Financial Performance

In 2025, Stenocare's revenue was 7.02 million, an increase of 214.56% compared to the previous year's 2.23 million. Losses were -2.39 million, -93.07% less than in 2024.

Financial numbers in DKK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error